Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCSW) Non-Current Debt (2021 - 2024)

Historic Non-Current Debt for HeartSciences (HSCSW) over the last 4 years, with Q4 2024 value amounting to $49470.0.

  • HeartSciences' Non-Current Debt changed N/A to $49470.0 in Q4 2024 from the same period last year, while for Oct 2024 it was $49470.0, marking a year-over-year change of. This contributed to the annual value of $500000.0 for FY2023, which is 8874.33% down from last year.
  • HeartSciences' Non-Current Debt amounted to $49470.0 in Q4 2024.
  • HeartSciences' 5-year Non-Current Debt high stood at $4.4 million for Q2 2022, and its period low was $49470.0 during Q4 2024.
  • Its 4-year average for Non-Current Debt is $1.0 million, with a median of $500000.0 in 2023.
  • Its Non-Current Debt has fluctuated over the past 5 years, first surged by 167530.26% in 2022, then crashed by 8874.33% in 2023.
  • HeartSciences' Non-Current Debt (Quarter) stood at $250200.0 in 2021, then soared by 299.68% to $1.0 million in 2022, then tumbled by 50.0% to $500000.0 in 2023, then plummeted by 90.11% to $49470.0 in 2024.
  • Its last three reported values are $49470.0 in Q4 2024, $500000.0 for Q3 2024, and $500000.0 during Q3 2023.